Essa Pharma Quote - EPI

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

8.20

Bid

6.50

Ask

8.95

Volume

0.00 Day's Range 0.00

8.20 52 Week Range 8.20

Market Cap

363.982M

Previous Close

8.20

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

44,388,000

Dividend Yield

PE Ratio

-2.72

Earnings Per Share (EPS)

-0.64

Revenue

Net Profit

-28.54M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.essapharma.com

Headquarters

Vancouver, British Columbia, Can

Founded

Essa Pharma Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Exchange with ticker EPI. The last closing price for Essa Pharma was $8.20. Over the last year, Essa Pharma shares have traded in a share price range of $ 8.20 to $ 8.20.

Essa Pharma currently has 44,388,000 shares outstanding. The market capitalization of Essa Pharma is $363.98 million. Essa Pharma has a price to earnings ratio (PE ratio) of -2.72.

ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders

ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders Canada NewsWire HOUSTON and VANCOUVER, BC, Feb. 25, 2021 HOUSTON and VANCOUVER, BC, Feb. 25, 2021 /CNW/...

ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castr...

ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castration-Resistant Prostate Cancer Canada NewsWire HOUSTON and VANCOUVER...

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2020 Canada NewsWire VANCOUVER and HOUSTON, Dec. 15, 2020 VANCOUVER and...

ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference

ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference Canada NewsWire HOUSTON and VANCOUVER, BC, Nov. 25, 2020 HOUSTON and VANCOUVER, BC, Nov. 25, 2020 /CNW/ - ESSA Pharma...

ESSA Pharma Inc. Announces Delisting from the TSX-V

ESSA Pharma Inc. Announces Delisting from the TSX-V Canada NewsWire HOUSTON and VANCOUVER, BC, Oct. 26, 2020 HOUSTON and VANCOUVER, BC, Oct. 26, 2020 /CNW/ - ESSA Pharma Inc. ("ESSA" or...

ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium

ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium Canada NewsWire HOUSTON and VANCOUVER, BC, Oct. 24, 2020 HOUSTON and VANCOUVER, BC, Oct. 24, 2020 /CNW/...

ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia

ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia Canada NewsWire HOUSTON, Texas and VANCOUVER, BC, Oct. 19, 2020 HOUSTON, Texas and...

ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit

ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit Canada NewsWire HOUSTON and VANCOUVER, BC, Sept. 21, 2020 HOUSTON and VANCOUVER, BC, Sept. 21, 2020...

ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020

ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020 Canada NewsWire HOUSTON and VANCOUVER, BC, Sept. 17, 2020 HOUSTON and...

ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resist...

ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resistant Prostate Cancer Canada NewsWire HOUSTON and VANCOUVER, BC, Sept...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	8.2	8.2	8.2	0	0	CS
4	0	0	8.2	8.2	8.2	0	0	CS
12	0	0	8.2	8.2	8.2	0	0	CS
26	0	0	8.2	8.2	8.2	0	0	CS
52	0	0	8.2	8.2	8.2	0	0	CS
156	0	0	8.2	8.2	8.2	0	0	CS
260	0.75	10.067114094	7.45	11.34	4	479	8.99622168	CS

EPI - Frequently Asked Questions (FAQ)

What is the current Essa Pharma share price?

The current share price of Essa Pharma is $ 8.20

How many Essa Pharma shares are in issue?

Essa Pharma has 44,388,000 shares in issue

What is the market cap of Essa Pharma?

The market capitalisation of Essa Pharma is CAD 363.98M

What is the 1 year trading range for Essa Pharma share price?

Essa Pharma has traded in the range of $ 8.20 to $ 8.20 during the past year

What is the PE ratio of Essa Pharma?

The price to earnings ratio of Essa Pharma is -2.72

What is the reporting currency for Essa Pharma?

Essa Pharma reports financial results in USD

What is the latest annual profit for Essa Pharma?

The latest annual profit of Essa Pharma is USD -28.54M

What is the registered address of Essa Pharma?

The registered address for Essa Pharma is SUITE 3500, THE STACK, 1133 MELVILLE STREET, VANCOUVER, BRITISH COLUMBIA, V6E 4E5

What is the Essa Pharma website address?

The website address for Essa Pharma is www.essapharma.com

Which industry sector does Essa Pharma operate in?

Essa Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AHRAmarc Resources Ltd	$ 0.72 (171.70%)	4.17M
OEG.HONEnergy Inc	$ 0.035 (133.33%)	14.66k
FYLFinlay Minerals Ltd	$ 0.045 (125.00%)	4.86M
CPICarlton Precious Inc	$ 0.16 (113.33%)	1,000
MVYMoovly Media Inc	$ 0.01 (100.00%)	1.5M
GAR.HGreen Arrow Resources Inc	$ 0.015 (-66.67%)	1.96k
CANDCandelaria Mining Corp	$ 0.005 (-50.00%)	553.7k
WWTWater Ways Technologies Inc	$ 0.005 (-50.00%)	79.65k
AZC.PA2ZCryptocap Inc	$ 0.045 (-50.00%)	33k
BYM.HBaymount Incorporated	$ 0.005 (-50.00%)	5k
FYLFinlay Minerals Ltd	$ 0.045 (125.00%)	4.86M
AGMRSilver Mountain Resources Inc	$ 0.05 (-9.09%)	4.23M
AHRAmarc Resources Ltd	$ 0.72 (171.70%)	4.17M
TDGTDG Gold Corp	$ 0.245 (75.00%)	4.08M
MATEBlockmate Ventures Inc	$ 0.33 (0.00%)	3.99M